IMPACT-FH Study for Implementing Innovative Family Communication and Cascade Testing Strategies for Familial Hypercholesterolemia

被引:2
作者
Jones, Laney K. [1 ,2 ]
Campbell-Salome, Gemme [1 ,3 ]
Walters, Nicole L. [1 ]
Brangan, Andrew [1 ]
Morgan, Kelly M. [1 ]
Tricou, Eric P. [4 ]
Mills, Zoe T. Lindsey [1 ]
McGowan, Mary P. [4 ]
Gidding, Samuel S. [1 ]
Johns, Alicia M. [5 ]
Kirchner, H. Lester [3 ]
Rahm, Alanna Kulchak [1 ]
Sturm, Amy C. [1 ,2 ,6 ]
机构
[1] Geisinger, Res Inst, Dept Genom Hlth, Danville, PA USA
[2] Geisinger, Heart & Vasc Inst, Danville, PA USA
[3] Geisinger, Res Inst, Dept Populat Hlth Sci, Danville, PA USA
[4] Family Heart Fdn, Pasadena, CA USA
[5] Geisinger, Res Inst, Biostat Core, Danville, PA USA
[6] 23andMe, Sunnyvale, CA USA
来源
JACC-ADVANCES | 2024年 / 3卷 / 09期
基金
美国国家卫生研究院;
关键词
cascade testing; family communication; familial hypercholesterolemia; implementation strategies; RELATIVES; CARE;
D O I
10.1016/j.jacadv.2024.101198
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Relatives of probands diagnosed with familial hypercholesterolemia (FH) should undergo cascade testing for FH. OBJECTIVES The purpose of this study was to evaluate probands'choices of innovative strategies to communicate their FH result with relatives and facilitate cascade testing uptake. METHODS Probands with an FH genetic result from the MyCode Community Health Initiative could choose to share their FH result with adult blood relatives via the Family and Healthcare Professional Packet (packet), family sharing and cascade chatbots (chatbot), and/or FH Outreach and Support Program (direct contact). Cascade testing uptake was measured as reported completion of genetic or cholesterol testing. Generalized estimating equations models were used to identify factors associated with testing. RESULTS A total of 175 probands received an FH result, median age was 58.9 (IQR: 44.9-69.3) years, and 58.9% were female. Probands shared information about 1,915 adult and 163 minor relatives (11.9 relatives per proband). Seventy percent of probands (121/175) selected at least one strategy for at least one adult relative. An average of 1.2 strategies was selected per adult relative. Cascade testing was completed for 26.6% (144/541) of adults with at least one strategy selected, 2.4% (33/1,374) of adults without a strategy selected, and 25.2% (41/163) of minor relatives. Factors associated with increased cascade testing uptake were selection of at least one strategy (6.32 higher odds), specifically, selection of direct contact (16.78 higher odds). CONCLUSIONS Strategies implemented improved FH cascade testing uptake compared to previous estimates and in families where no strategy was selected. Overall uptake remains insufficient, which can be attributed to probands reluctance to select a strategy for many relatives. (JACC Adv. 2024;3:101198) (c) 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:12
相关论文
共 28 条
[21]   A pragmatic clinical trial of cascade testing for familial hypercholesterolemia [J].
Miller, Alexandra A. ;
Bangash, Hana ;
Smith, Carin Y. ;
Wood-Wentz, Christina M. ;
Bailey, Kent R. ;
Kullo, Iftikhar J. .
GENETICS IN MEDICINE, 2022, 24 (12) :2535-2543
[22]   Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease [J].
Nordestgaard, Borge G. ;
Chapman, M. John ;
Humphries, Steve E. ;
Ginsberg, Henry N. ;
Masana, Luis ;
Descamps, Olivier S. ;
Wiklund, Olov ;
Hegele, Robert A. ;
Raal, Frederick J. ;
Defesche, Joep C. ;
Wiegman, Albert ;
Santos, Raul D. ;
Watts, Gerald F. ;
Parhofer, Klaus G. ;
Hovingh, G. Kees ;
Kovanen, Petri T. ;
Boileau, Catherine ;
Averna, Maurizio ;
Boren, Jan ;
Bruckert, Eric ;
Catapano, Alberico L. ;
Kuivenhoven, Jan Albert ;
Pajukanta, Paeivi ;
Ray, Kausik ;
Stalenhoef, Anton F. H. ;
Stroes, Erik ;
Taskinen, Marja-Riitta ;
Tybjaerg-Hansen, Anne .
EUROPEAN HEART JOURNAL, 2013, 34 (45) :3478-+
[23]   Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature [J].
Roberts, Megan C. ;
Dotson, W. David ;
DeVore, Christopher S. ;
Bednar, Erica M. ;
Bowen, Deborah J. ;
Ganiats, Theodore G. ;
Green, Ridgely Fisk ;
Hurst, Georgia M. ;
Philp, Alisdair R. ;
Ricker, Charite N. ;
Sturm, Amy C. ;
Trepanier, Angela M. ;
Williams, Janet L. ;
Zierhut, Heather A. ;
Wilemon, Katherine A. ;
Hampel, Heather .
HEALTH AFFAIRS, 2018, 37 (05) :801-808
[24]   Use of a chatbot to increase uptake of cascade genetic testing [J].
Schmidlen, Tara ;
Jones, Claire L. ;
Campbell-Salome, Gemme ;
McCormick, Cara Z. ;
Vanenkevort, Erin ;
Sturm, Amy C. .
JOURNAL OF GENETIC COUNSELING, 2022, 31 (05) :1219-1230
[25]   A Model for Genome-First Care: Returning Secondary Genomic Findings to Participants and Their Healthcare Providers in a Large Research Cohort [J].
Schwartz, Marci L. B. ;
McCormick, Cara Zayac ;
Lazzeri, Amanda L. ;
Lindbuchler, D'Andra M. ;
Hallquist, Miranda L. G. ;
Manickam, Kandamurugu ;
Buchanan, Adam H. ;
Rahm, Alanna Kulchak ;
Giovanni, Monica A. ;
Frisbie, Lauren ;
Flansburg, Carroll N. ;
Davis, F. Daniel ;
Sturm, Amy C. ;
Nicastro, Christine ;
Lebo, Matthew S. ;
Mason-Suares, Heather ;
Mahanta, Lisa Marie ;
Carey, David J. ;
Williams, Janet L. ;
Williams, Marc S. ;
Ledbetter, David H. ;
Faucett, W. Andrew ;
Murray, Michael F. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2018, 103 (03) :328-337
[26]   Cardiovascular Cascade Genetic Testing: Exploring the Role of Direct Contact and Technology [J].
Sturm, Amy C. .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2016, 3
[27]   Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands [J].
Umans-Eckenhausen, MAW ;
Defesche, JC ;
Sijbrands, EJG ;
Scheerder, RLJM ;
Kastelein, JJP .
LANCET, 2001, 357 (9251) :165-168
[28]   Child-Parent Familial Hypercholesterolemia Screening in Primary Care [J].
Wald, David S. ;
Bestwick, Jonathan P. ;
Morris, Joan K. ;
Whyte, Ken ;
Jenkins, Lucy ;
Wald, Nicholas J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (17) :1628-1637